Company presentation by Hans Jeppsson, CFO
Report on the ATTRACT study
Idiopathic Pulmonary Fibrosis: 5 Things to Know
C21 shows promise against COVID-19 where other drugs have failed
Idiopathic Pulmonary Fibrosis (IPF) – weathering the pandemic
Top line data on the ATTRACT study